Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention methods and risk factors for fentanyl-induced cough
ChiCTR-TRC-09000428Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Dec 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl, lidocaine, ephedrine and propofol in cough (8 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Incidence and severity of cough after fentanyl injection and Possible factors associated with fentanyl-induced cough. Started Dec 2007; status: completed.
02
Drugs
fentanyllidocaineephedrinepropofol
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR-TRC-09000428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000428.